Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome

摘要

Toll‐like receptors (TLRs) are involved in colorectal cancer (CRC) pathogenesis. However, the significance of serum TLR concentrations in CRC is unknown. We analyzed serum TLR2 and TLR4 concentrations with ELISA in preoperative samples from 118 patients with CRC and 88 matched controls. We also assessed?tissue TLR expression with immunohistochemistry and by detecting serum?determinants of systemic inflammation. Most participants (70%) had undetectable serum TLR2. The mean serum TLR4 levels were lower in patients than in controls (1.1 vs 1.8?ng/mL; p?=?0.015). Undetectable TLR4 was more common in stage I (39%) than in stages II–IV (11%, p??0.001). TLR2 or TLR4 expression in tumor cells did not correlate with serum levels, but abundant TLR2 expression in normal colon epithelium was associated with detectable serum TLR2 (p?=?0.034). Undetectable serum TLR2 was linked to high modified Glasgow prognostic scores (p?=?0.010), high CRP levels (p?=?0.013), blood vessel invasion (p?=?0.013), and tended to be associated with worse 5‐year survival (p?=?0.052). In conclusion, serum TLR2 levels were inversely associated with systemic inflammation in patients with CRC. Moreover, serum TLR2 levels might depend more on normal colorectal mucosa contributions than on tumor tissue contributions. Further studies are required to assess the prognostic value of serum TLR2.